Rigid H<sub>4</sub>OCTAPA derivatives as model chelators for the development of Bi(<scp>iii</scp>)-based radiopharmaceuticals-Reference-Cited by-同舟云学术

Rigid H₄OCTAPA derivatives as model chelators for the development of Bi(iii)-based radiopharmaceuticals

Published:2023 Issue:23 Volume:59 Page:3443-3446
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Lucio-Martínez Fátima¹^ORCID,Esteban-Gómez David¹^ORCID,Valencia Laura²^ORCID,Horváth Dávid³⁴,Szücs Dániel³⁴⁵,Fekete Anikó⁵,Szikra Dezső⁵,Tircsó Gyula³^ORCID,Platas-Iglesias Carlos¹^ORCID

Affiliation:

1. Universidade da Coruña, Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química, Facultade de Ciencias, 15071, A Coruña, Galicia, Spain

2. Departamento de Química Inorgánica, Facultad de Ciencias, Universidade de Vigo, As Lagoas, Marcosende, Pontevedra 36310, Spain

3. Department of Physical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, Debrecen H-4032, Hungary

4. Doctoral School of Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, Debrecen H-4032, Hungary

5. Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., Debrecen H-4032, Hungary

Abstract

Non-macrocyclic H4OCTAPA derivatives form highly stable complexes with Bi(iii), but require an appropriate rigid spacer to enhance the inertness of the complex, as demonstrated by radiolabeling studies with 205/206Bi-nuclides.

Funder

Xunta de Galicia

Ministerio de Ciencia e Innovación

Debreceni Egyetem

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2023/CC/D2CC06876A

Reference33 articles.

1. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles

2. The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications

3. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy

4. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”

5. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the use of rigid 18-membered macrocycles with amide pendant arms for Pb(ii)-based radiopharmaceuticals;Inorganic Chemistry Frontiers;2024

2. Unravelling the 6sp ← 6s absorption spectra of Bi(iii) complexes;Dalton Transactions;2024

3. Synthesis of new acyclic chelators H4aPyta and H6aPyha and their complexes with Cu²⁺, Ga³⁺, Y³⁺, and Bi³⁺;Dalton Transactions;2024